Abstract
Keywords
Mouse Sciatic nerve Odontobuthus doriae Venom Iranian scorpion
Introduction
The venom of scorpions has potent neurotoxins affecting the neuromuscular transmission at either presynaptic or post-synaptic levels. Presynaptic-acting neurotoxins (β-neurotoxins)
inhibit the release of massive amounts of neurotransmitters, mainly acetylcholine and/ or noradrenalin, while post-synaptic-acting neurotoxins (α-neurotoxins) cause a reversible blockage of acetylcholine receptors (1, 2). These effects induce and cause central and peripheral neurotoxicity, cardiotoxicity and metabolic alterations (3-5). These toxins have an effect on the normal function of excitable tissues found in muscles and nerves by interaction with Na+ , K+ , Ca2+ or Cl- channels (6, 7). These basic and low molecular-weight peptides are of great interest in neurobiology and pharmacology.
The Iranian yellow scorpion O. doriae is a member of the Buthidae family and is especially found in the central and southern part of Iran (Figure 1). The genus Buthus has two species: doriae and odonturus (8). O. doriae venom is able to interact with some voltage-dependent sodium (Nav) and potassium channels (Kv) (9- 12). Thus far, a venom component has shown to be highly subtype-selective for a Nav isoform, Nav1.7 (13).
Its stings cause various effects ranging from local pain, inflammation, necrosis, hematological effects (12), and neurotoxicity. The early neurotoxicity, within a few hours, develops rapidly, leading to a range of temporary paralysis. Temporary paralysis covers a range of injuries ranging from mild, moderate to severe, permanent paralysis, affecting as little as one muscle group to as much as the full body. Although this sign occurs rarely, almost in severe envenoming,underlying exact mechanism was needed to take into account. Considering the strength and wide spread of stings by this scorpion in center parts of Iran (Figure 1), a sciatic etiology remains the most probable, perhaps accentuated by individual susceptibility or age. Therefore, the present hypothesis was designed to raise the knowledge on the motor nerve terminal activity of the sciatic nerve following the inoculation of scorpion venom. In addition, in order to advance our understanding of the mechanism of neuromuscular transmission blockage in-vitro, the influence of temperature in the event of progression of neurotoxicity and complications of envenoming was investigated in the MHD preparation.
Experimental
Study design and population
A total of 15 healthy, adult, clean grade BALB/c, male, mice, aged 8 weeks, weighing 25 ± 2 g, were provided. All mice were housed in groups of five and maintained under a 12-h light-dark cycle in a temperature-controlled environment (20 ± 22°C) for at least 10 days prior to the experiments. Food and water were freely available. Animal handling procedures were in accordance with the guidelines for animal care prepared by Committee on Care and Use of Laboratory Animal resources, National Research Council, USA.
Materials
Crude venom was obtained by electrical stimulating the telson of scorpion and after freeze-dried was stored at - 50°C until used.
Mouse phrenic nerve-hemidiaphragm (MHD) preparation
Mice (20-25 g) were killed using CO2 and decapitated. Hemidiaphragm and the attached phrenic nerves were dissected from the animals in the same way as described for the rat phrenichemidiaphragm preparation as described previously (14). The nerves were mounted in 5 mL tissue bath containing Krebs physiological solution at 37°C and gassed with 95% O2 + 5% CO2 (pH = 7.3). The composition of the Krebs physiological solution was as follows: NaCl, 118.4; KH2PO4, 1.2; glucose, 11.1; NaHCO3, 25; CaCl2, 2.5; MgSO4, 1.4 and KCl, 4.7. The preparations were mounted on an electrode enabled to stimulate the nerve directly. For indirect stimulation, the phrenic nerve was stimulated by pulses with a voltage greater than that required to produce a maximal response. A single pulse generated by an electronic stimulator (Grass S88B, Quincy, MA) was delivered to induce a twitch at a frequency of 0.1 Hz with pulses of 0.2 ms duration.
Resting membrane potential recording
Intracellular recordings of the Resting membrane potential (RMP) potential were performed on unstimulated fibers equilibrated in standard physiological solution. This solution was contained 100 μM tubocurarine to overcome any possible effect of venom due to acetylcholine release from nerve terminal.
RMP was measured by standard microelectrode techniques (Fatt and Katz, 1951). Muscle fibers of mouse sciatic nerve were depolarized by exposure to venom (1 μg/ mL). The glass microelectrode filled with 3M KCl (resistance: 10-20 MΏ) was inserted into a muscle fiber at an endplate region. Recording sites were rejected if the membrane potentials were less than 60 mV on the initial implement or the membrane potentials varied by more than 10% during the first 20 min of control recording.
Mouse sciatic nerve recording
A 5-7 cm long sciatic nerve, comprising proximal and distal regions, was dissected out. The preparation was then mounted into a recording chamber consisting of three cylindrical compartments of 1 mL capacity each. Electrical isolation between the compartments was achieved using Vaseline. The two external compartments were filled with physiological buffer (15). The composition (mM) of physiological buffer was as follows: NaCl, 154; KCl, 5; MgCl2, 1.25; glucose, 11; HEPES, 5.46; CaCl2, 1.8; pH = 7.4. The central compartment contained the 1 mg/mL venom. Before each experiment the solution was saturated with 100% O2 for 30 min. Pellet type silver electrodes were dipped into each of the compartments of the recording chamber with stimulation taking place between the central and one of the external compartments. The ground electrode was dipped into the central pool. Recording were obtained from the central pool. A Grass S48 stimulator was used to supply electrical impulses (0.4 Hz, 0.04 ms duration) supra-maximally via a stimulus isolation unit, model SIU 5A (Grass Instrument Co., Quincy, Mass., USA). Signals were amplified with a CED 1902 transducer, digitized by an analogue-digital converter CED 1401 and analyzed with a microcomputer program (Dempster, 1988). Experiments were carried out at room temperature of 20 ± 2°C. The sciatic nerve preparation was incubated in physiological buffer for 30 min under constant super-maximal stimulation to demonstrate viability in the preparation and consistency in the recordings.
Statistical analysis
The measurements were expressed as the mean ± SEM (n = 3). Differences between groups or treatments were compared using Student’s t-test with p < 0.05 indicating significance.
Results
Effects of the venom on responses to indirect stimulation of mouse hemidiaphragm (MHD) preparations at room temperature
O. doriae venom, tested on indirectly stimulated preparations, caused a transient augmentation in twitches followed by a contracture, and then increasing in resting tension coincided with the reduction of twitch height until a complete irreversible suppression. A transient increase due to 1 μg/mL venom was slower at room temperature (20-22°C) compared with effects seen at 37°C. There was no significant difference in augmentation seen in room temperature compared with 37°C (Figure 2).
Effects of the venom on resting membrane potentials of muscle fibers
The RMP significantly decreased 80 and 60% after 10 and 30 min, respectively compared to control (p < 0.05; n = 3). RMP was decreased from - 75 ± 2.3 mV to - 60 ± 3.6 mV and – 45 ± 2.3, after 10 and 30 min, respectively. The depression was remained up to 40 min. The time-response relationship of venom-induced depression of RMP was significant (p < 0.05).
Effects of venom on mouse sciatic nerve
Venom (1 μg/mL) affected on both negative and positive components of the waveform which is known as a compound action potential. The venom after 40 min exposure abolished the negative part of the waveform and reduced the amplitude of the positive spike. Other characterization of the waveform remained similar to control (Figure 3).
Discussion
To underlying the mechanism of action of temporary paralysis following an O. doriae sting, the experiments were performed on compound action potentials recorded from isolated preparations of mice sciatic nerve. Injury to the sciatic nerve causes weakness or paralysis of one hind leg in human and the animal is well known. So, we aimed to elucidate whether sciatic nerve neurotoxicity or reversible neuromuscular transmission blockage underlie this association.
The mouse hemidiaphragm (MHD) preparation as a neuromuscular junction is the physiologic target for many venoms or highly selective toxins acting presynaptically and/or post-synaptically on ion channels and receptors.
Therefore, it was of interest to determine the effects of venoms or toxins on isolated mouse MHD preparations. In MHD preparation, presynaptic effect of the venoms abolishes or reduces nerveevoked responses, without affecting responses to cholinoceptor agonist or KCl-induced contracture of the muscle. Postsynaptic receptor effects of venoms decrease or block responses of the muscle to nerve stimulation and cholinoceptor agonists as well, but would not affect responses to direct muscle stimulation or to elevated KCl. In contrast, myotoxin could reduce or block the responses of a skeletal muscle to direct electrical stimulation, to elevated extracellular KCl, to nerve stimulation and cholinoceptor agonist (16, 17).
O. doriae venom possesses highly specific toxicity towards neuromuscular preparations.
At the MHD preparation, venom acts primarily by causing triphasic changes (depression, facilitation and final blockade) of twitch tension of motor nerve terminal. There were also immediate contractures in muscle fibers, which probably were due to massive release of acetylcholine from the endplate. We described the effect of the venom on chick biventer cervicis preparations, in which inhibition of twitchtension and KCl-induced contractures was observed (11). High concentrations of venom and its myotoxic component were necessary to cause neuromuscular blockade. Indeed, as reported by Harvey et al. (16), low venom concentrations frequently expose the presence of neurotoxins, while high concentrations are required to demonstrate the presence of myotoxic components. Therefore, the concentration of 1 μg/mL of venom was selected for the experiments.
The O. doriae scorpion venom reduced the amplitude of the second component of the sciatic preparation followed by abolishing the reverse phase. The perineural waveform in normal conditions consists mainly of two downward negative spikes, the first of which corresponds to the inward sodium currents at the final nodes of Ranvier, and the second of which reflects the outward flow of potassium ions at the distant nerve terminals (18). It completely abolished the second negative component of the waveform. Longer exposure caused a small decrease in the amplitude of the first positive component of compound action potential.
Studies have shown that the venom or toxins that reduce the second negative component able to facilitate the release of acetylcholine (19, 20). Suppression of the potassium current at nerve terminals would probably lead to a slower repolarization of the nerve terminal and consequently, allow calcium channels to open for longer durations. The effect of the venom in initiating muscle contractility has been attributed to interference with the stabilizing function of calcium at the muscle membrane (21).
O. doriae scorpion venom contains both α-like toxin OD1, which slow sodium channel inactivation, as well as toxins affecting on potassium channel, which causes a negative shift in the conductance-voltage relationship of the potassium channel (9, 10, 12, 13). So, O. doriae venom contains toxins, which act on ion channels causes either polarization or depolarization of excitable membranes such as sciatic nerve, which affects the action potential and neuromuscular function (22). In addition, venom prolongs the action potential of the sciatic nerve. These changes may increase the presynaptic release on neurotransmitters, including catecholamine (23), acetylcholine (24), glutamate (25), and GABA (26), contributing to the observed of neurotoxicity in O. doriae envenomed patients. This conclusion is augmented with no change in sciatic nerve preparation exposed to Conus geographus venom (27). The Conus geographus venom did not emerge to block sodium ion transport and did not affect the action potentials in the prepared nerve preparations.
Since the effects of the venom were going to be tested in electrophysiological experiments at room temperature, the effects of venom (1 μg/mL) at 37°C were compared with those at room temperature. The rate of augmentation was slightly faster at room temperature than 37°C, although the pattern of augmentations was similar. Same effects have been studied experimentally with previous studies (20, 28, 29). These effects have been attributed to the dependence of transmission efficiency on temperature. As suggested by previous studies conducted on the snake venoms, the influence of temperature upon the toxins induced neuromuscular blockade strongly showed the involvement of the enzymatic activity of PLA2 in the snake venom neurotoxicity (30).
Our observation did not show a temperaturedependent blockade of the neuromuscular transmission in MHD preparation. So the results reported here constitute the first evidence that neurotoxicity caused by scorpion venom at the neuromuscular preparation level may not be dependent on the PLA2 enzymatic activity. It means that neurotoxicity of scorpion venom don›t related to the PLA2 as showed in snake venoms.
Conclusion
It is not fully recognized whether O. doriae directly affects the sciatic nerve via channels or acts via neurotransmitters and inflammatory mediators. Based on the present results, O. doriae venom causes a strong depolarization of the channels, followed by a drop in excitability, leading to a temporary paralysis in the sciatic nerve. O. doriae toxins mainly Nav isoforms prolong the action potential of the sciatic nerve and induce temporary paralysis. However, the influence of temperature on neurotoxicity was ineffective on blockade of the neuromuscular transmission in-vitro.
Acknowledgements
References
-
1.
Sabatier JM. Animal venoms: from deadly arsenals (toxins) to therapeutic drug candidates. InflammAllergy Drug Targets. 2011 10;10(5):312.
-
2.
Whitehead CF. Animal toxins. Br J Anaesth. 1995 9;75(3):372. [PubMed ID: 7547066].
-
3.
Ismail M. Treatment of the scorpion envenoming syndrome: 12-years experience with serotherapy. Int.J. Antimicrob. Agents. 2003;21(2):170-4. [PubMed ID: 12615382].
-
4.
Ismail M. The scorpion envenoming syndrome. Toxicon. 1995;33(7):825-58. [PubMed ID: 8588209].
-
5.
Freire-Maia L, Campos JA, Amaral CF. Approaches to the treatment of scorpion envenoming. Toxicon. 1994;32(9):1009-14. [PubMed ID: 7801334].
-
6.
Becerril B, Marangoni S, Possani LD. Toxins and genes isolated from scorpions of the genus Tityus. Toxicon. 1997;35(6):821-35. [PubMed ID: 9241777].
-
7.
Mandal MB, Deshpande SB. Ca2+ -free medium enhances the magnitude of slow peak in compound action potential of frog sciatic nerve in-vitro. Indian J.Exp. Biol. 2004;42(1):43-7. [PubMed ID: 15274479].
-
8.
Latifi M, Tabatabai M. Immunological studies on Iranian scorpion venom and antiserum. Toxicon. 1979;17(6):617-21. [PubMed ID: 118550].
-
9.
Abdel-Mottaleb Y, Clynen E, Jalali A, Bosmans F, Vatanpour H, Schoofs L, Tytgat J. The first potassium channel toxin from the venom of the Iranian scorpion Odonthobuthus doriae. FEBS Lett. 2006;580(26):6254-8. [PubMed ID: 17070524].
-
10.
Abdel-Mottaleb Y, Vandendriessche T, Clynen E, Landuyt B, Jalali A, Vatanpour H, Tytgat J. OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae. Toxicon. 2008;51(8):1424-30. [PubMed ID: 18471844].
-
11.
Jalali A, Vatanpour H, Hosseininasab Z, Rowan EG, Harvey AL. The effect of the venom of the yellow Iranian scorpion Odontobuthus doriae on skeletal muscle preparations in-vitro. Toxicon. 2007;50(8):1019-26. [PubMed ID: 17976675].
-
12.
Jalali A, Bosmans F, Amininasab M, Clynen E, Cuypers E, Zaremirakabadi A, Sarblouki MN, Schoofs L, Vatanpour H, Tytgat J. OD1, the first toxin isolated from the venom of the scorpion Odonthobuthus doriae active on voltage-gated Na+ channels. FEBS Lett. 2005;579(19):4181-6. [PubMed ID: 16038905].
-
13.
Maertens C, Cuypers E, Amininasab M, Jalali A, Vatanpour H, Tytgat J. Potent modulation of the voltage-gated sodium channel Nav1.7 by OD1, a toxin from the scorpion Odonthobuthus doriae. Mol. Pharmacol. 2006;70(1):405-14. [PubMed ID: 16641312].
-
14.
Ganguly DK, Nath DN, Ross HG, Vedasiromoni JR. Rat isolated phrenic nerve-diaphragm preparation for pharmacological study of muscle spindle afferent activity: effect of oxotremorine. Br. J. Pharmacol. 1978;64(1):47-52. [PubMed ID: 151569].
-
15.
Paparounas K, O›Hanlon GM, O›Leary CP, Rowan EG, Willison HJ. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in-vitro. Brain. 1999;122(Pt 5):807-16. [PubMed ID: 10355667].
-
16.
Harvey AL, Barfaraz A, Thomson E, Faiz A, Preston S, Harris JB. Screening of snake venoms for neurotoxic and myotoxic effects using simple in-vitro preparations from rodents and chicks. Toxicon. 1994;32(3):257-65. [PubMed ID: 8016848].
-
17.
Rowan EG, Harvey AL. Potassium channel blocking actions of beta-bungarotoxin and related toxins on mouse and frog motor nerve terminals. Br. J.Pharmacol. 1988;94(3):839-47. [PubMed ID: 3263160].
-
18.
Mallart A. Electric current flow inside perineurial sheaths of mouse motor nerves. J. Physiol. 1985;368:565-75. [PubMed ID: 2416919].
-
19.
Anderson AJ, Harvey AL. Effects of the potassium channel blocking dendrotoxins on acetylcholine release and motor nerve terminal activity. Br. J. Pharmacol. 1988;93(1):215-21. [PubMed ID: 2450611].
-
20.
Marshall DL, Harvey AL. Block of potassium channels and facilitation of acetylcholine release at the neuromuscular junction by the venom of the scorpion, Pandinus imperator. Toxicon. 1989;27(4):493-8. [PubMed ID: 2728034].
-
21.
Harvey AL, Vatanpour H, Rowan EG, Pinkasfeld S, Vita C, Menez A, Martin-Eauclaire MF. Structureactivity studies on scorpion toxins that block potassium channels. Toxicon. 1995;33(4):425-36. [PubMed ID: 7570628].
-
22.
Catterall WA, Cestele S, Yarov-Yarovoy V, Yu FH, Konoki K, Scheuer T. Voltage-gated ion channels and gating modifier toxins. Toxicon. 2007;49(2):124-41. [PubMed ID: 17239913].
-
23.
Ito S, Nakazato Y, Ohga A. Further evidence for the involvement of Na+ channels in the release of adrenal catecholamine: the effect of scorpion venom and grayanotoxin I. Br. J. Pharmacol. 1981;72(1):61-7. [PubMed ID: 6261866].
-
24.
Gwee MC, Nirthanan S, Khoo HE, Gopalakrishnakone P, Kini RM, Cheah LS. Autonomic effects of some scorpion venoms and toxins. Clin. Exp. Pharmacol.Physiol. 2002;29(9):795-801. [PubMed ID: 12165045].
-
25.
Massensini AR, Romano-Silva MA, Gomez MV. Sodium channel toxins and neurotransmitter release. Neurochem. Res. 2003;28(10):1607-11. [PubMed ID: 14570407].
-
26.
Purali N. Stimulation of GABA release by scorpion venom in an isolated synapse in the crayfish (Astacus leptodactylus). Toxicon. 2003;41(3):383-9. [PubMed ID: 12565762].
-
27.
McIntosh JM, Dowell C, Watkins M, Garrett JE, Yoshikami D, Olivera BM. Alpha-conotoxin GIC from Conus geographus, a novel peptide antagonist of nicotinic acetylcholine receptors. J. Biol. Chem. 2002;277(37):33610-5. [PubMed ID: 12114524].
-
28.
Hamilton JL, Edwards CR, Holt SR, Worden MK. Temperature dependent modulation of lobster neuromuscular properties by serotonin. J. Exp. Biol. 2007;210(Pt 6):1025-35. [PubMed ID: 17337715].
-
29.
Ishii Y, Watari T, Tsuchiya T. Enhancement of twitch force by stretch in a nerve-skeletal muscle preparation of the frog Rana porosa brevipoda and the effects of temperature on it. J. Exp. Biol. 2004;207(Pt 26):4505-13. [PubMed ID: 15579546].
-
30.
Gallacci M, Nascimento N, Rogero JR, Vassilieff VS. Influence of temperature upon effects of crotoxin and gamma-irradiated crotoxin at rat neuromuscular transmission. Toxicol. Lett. 2000;114(1-3):77-80. [PubMed ID: 10713471].